Lv1
15 积分 2022-07-09 加入
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
1天前
待确认
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease
1天前
已完结
Biologically Active Pyridazines and Pyridazinone Derivatives: A Scaffold for the Highly Functionalized Compounds
1天前
已完结
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
1天前
已完结
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease
3天前
已完结
Discovery, Synthesis, and Biological Mechanism Evaluation of Novel Quinoline derivatives as Potent NLRP3 Inhibitors
13天前
已完结
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease
2个月前
已完结
Development of novel bisphenol derivatives with a membrane-targeting mechanism as potent gram-positive antibacterial agents
2个月前
已完结
Development of novel bisphenol derivatives with a membrane-targeting mechanism as potent gram-positive antibacterial agents
2个月前
已完结
Development of Novel Bisphenol Derivatives with a Membrane-Targeting Mechanism as Potent Gram-positive Antibacterial Agents
2个月前
已完结
皖公网安备34019202002308
